Pharmacogenetic expression of cyp2c19 in a pediatric population

HIGHLIGHTS

  • who: Marie Josette Déborah Pierre-François and collaborators from the Department of Pharmacology and Physiology, University of Montréal, Montreal, QC H C , Canada have published the article: Pharmacogenetic Expression of CYP2C19 in a Pediatric Population, in the Journal: (JOURNAL) of 28/04/2022
  • what: In view of the well-characterized pharmacokinetics of this gene-drug interaction and the presence of fully mature CYP2C19 enzyme activity after 2-3 months of age, it is reasonable to extrapolate adult recommendations to pediatric patients if necessary. The aim of this study was to describe trends . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?